Lung cancer remains one of the most prevalent and deadly forms of cancer worldwide and is expected to be the most commonly diagnosed cancers in Canada in 2022. However, in recent years, the importance of lung cancer screening has emerged as a crucial tool in the fight against this formidable foe.
By detecting lung cancer in its early stages, lung cancer screening has the potential to significantly improve survival rates and enhance overall patient outcomes. Early detection allows for timely intervention and appropriate treatment strategies. Lung cancer screening aims to detect the disease before symptoms manifest, enabling healthcare professionals to intervene when the cancer is still localized and more easily treatable.
In BC it is recommended that all high risk patients get lung cancer screening. The high-risk group typically includes individuals who are between 55 and 74 years old, are current or past smoker and have a history of smoking for 20yrs or more. However, it is important to consult with a healthcare professional to determine individual risk factors and determine the appropriateness of screening.
The lung cancer screening test involves low-dose computed tomography (LDCT) (a type of CT scan). LDCT scans use lower radiation doses than conventional CT scans, making them suitable for repeated screening in high-risk individuals. These scans can detect lung nodules or abnormalities that may indicate the presence of cancerous cells. While screening can lead to false-positive results, resulting in unnecessary follow-up tests and anxiety, the potential benefits of early detection outweighs these risks.
Book an appointment today to discuss your lung cancer risks and to see if screening is appropriate for you.